pharmachologic effect
Glycine is a substance that is a non-essential amino acid. Under its influence, metabolic processes in brain tissue become more active and an antioxidant effect is provided. Glycine also regulates the activity of glutamate receptors. As a result, a person’s conflict, aggressiveness, and psycho-emotional stress decrease. The patient's mood improves, the drug helps overcome symptoms of insomnia , symptoms of vegetative-vascular disorders, disorders in people who have recently suffered a traumatic brain injury or ischemic stroke . In addition, glycine reduces the degree of toxic effects of ethanol on the central nervous system.
Pharmacological properties
Pharmacotherapeutic group:
metabolic agent.
ATX code:
N06BX.
Pharmacodynamics: Glycine is an amino acid and one of the main inhibitory neurotransmitters in the brain. Glycine normalizes and activates protective inhibition processes in the central nervous system, reduces psycho-emotional stress, and increases mental performance.
Glycine has glycine- and GABA-ergic, alpha1-adrenergic blocking effects, regulates the activity of glutamate (NMDA) receptors.
The drug has the following properties:
- – reduces psycho-emotional stress, aggressiveness, conflict, increases social adaptation;
- – improves mood;
- – makes it easier to fall asleep and normalizes sleep;
- – increases mental performance;
- – reduces vegetative-vascular disorders (including during menopause);
- – reduces the severity of brain disorders in ischemic stroke and traumatic brain injury;
- – reduces the toxic effect of alcohol and other drugs that depress the function of the central nervous system.
Pharmacokinetics:
easily penetrates into most biological fluids and tissues of the body, incl. into the brain; metabolized to water and carbon dioxide; accumulation in the body does not occur.
Indications for use Glycine Bio
There are the following indications for the use of Glycine Bio:
- stressful condition , which provokes a state of psycho-emotional tension;
- deviant behavior in adolescents and children;
- deterioration of mental performance;
- diseases of the nervous system of a functional and organic nature, in which there is a high level of excitability and emotional stress;
- insomnia, other sleep disorders associated with neuroses, vegetative dystonia, various forms of encephalopathy (including those associated with alcohol abuse);
- cerebral infarction.
The drug is used in narcology for treatment during remission in encephalopathy and NS lesions.
Directions for use and doses
Glycine is used sublingually or buccally (in tablets or in powder form after crushing the tablets): adults, adolescents and children over three years old - 1 tablet (100 mg), children under three years old - 0.5 tablets (50 mg).
Glycine is prescribed to practically healthy children, adolescents and adults for psycho-emotional stress, stress nervous disorders, decreased memory, attention, mental performance, mental retardation, and deviant forms of behavior: 2-3 times a day for 14-30 days.
For functional and organic lesions of the nervous system, accompanied by increased excitability, emotional lability and sleep disturbance:
- – children under three years of age: 2-3 times a day for 7-14 days, then 1 time a day for 7-10 days, daily dose - 100-150 mg, course dose - 2000-2600 mg;
- – children over three years old, adolescents and adults: 2-3 times a day for 7-14 days, daily dose - 200-300 mg, course dose - 2800-4200 mg;
On the recommendation of a doctor, the course of treatment can be increased to 30 days; if necessary, the course is repeated after 30 days.
For sleep disorders: 20 minutes before bedtime or immediately before bedtime, 0.5-1 tablet (depending on age).
For ischemic cerebral stroke: during the first 3-6 hours from the onset of stroke, 1000 mg is prescribed sublingually or buccally with one teaspoon of water, then for 1-5 days 1000 mg per day, then over the next 30 days 1-2 tablets 3 times a day.
In narcology, glycine is used as a means of increasing mental performance and reducing psycho-emotional stress during the period of remission in cases of encephalopathy, organic lesions of the central and peripheral nervous system: 1 tablet 2-3 times a day for 14-30 days. If necessary, courses are repeated 4-6 times a year.
Instructions for use Glycine Bio (Method and dosage)
Instructions for use provide for transbuccal or sublingual use of tablets. In stressful situations, memory deterioration, decreased performance, as well as deviant behavior , adult patients and children are advised to take 100 mg of the drug 2-3 times a day. Treatment can last up to 1 month.
If the patient is diagnosed with lesions of the nervous system , in which symptoms of excitability and emotional arousal are noted, the drug is prescribed to children under three years of age in a dose of 50 mg Glycine Bio 2-3 times a day for 1-2 weeks, children after three years of age should receive 100 mg 2-3 times a day. The course can last from 1 to 4 weeks.
If the patient has sleep disorders , then, depending on the person’s age, he needs to take 50-100 mg of the drug before going to bed.
Patients with cerebral infarction need to take 1 g of the drug in the first 3-6 hours after the onset of stroke . In the next 1-5 days you should take 1 g of the product per day, then for another 30 days. 100-200 mg three times a day.
In drug treatment practice, 100 mg is prescribed 2-3 times a day, treatment lasts from 2 to 4 weeks.
Glycine-bio pharmaplant 100 mg 50 pcs. sublingual tablets
pharmachologic effect
Metabolic agent.
Composition and release form Glycine-bio pharmaplant 100 mg 50 pcs. sublingual tablets
1 tablet contains the active substance: glycine - 100 mg.
50 tablets per contour package.
Description of the dosage form
Tablets are white or almost white, round, biconvex with a cross-shaped score. Minor marbling is allowed.
Directions for use and doses
Sublingual or buccal 250 mg (in tablets or in powder form after crushing the tablets).
For children, adolescents and adults with psycho-emotional stress, decreased memory, attention, mental performance, mental retardation, and deviant forms of behavior, glycine is prescribed ½ tablet 2-3 times a day for 14-30 days.
For functional and organic lesions of the nervous system, accompanied by increased excitability, emotional lability and sleep disturbances, children under 3 years of age are prescribed ¼ tablet 2-3 times a day for 7-14 days, then ¼ tablet 1 time per day for 7-10 days. Daily dose - 100-150 mg, course dose - 2-2.6 g.
Children over 3 years of age and adults are prescribed ½ tablet 2-3 times a day, the course of treatment is 7-14 days, it can be increased to 30 days, if necessary, the course is repeated after 30 days.
For sleep disorders, ¼-½ tablets are prescribed 20 minutes before bedtime or immediately before bedtime (depending on age).
For ischemic cerebral stroke: during the first 3-6 hours from the onset of stroke, 1 g (4 tablets) is prescribed buccally or sublingually with 1 teaspoon of water, then for 1-5 days, 1 g / day (4 tablets), then over the next 30 days, ½-1 tablet 3 times a day.
In narcology - ½ tablet 2-3 times a day for 14-30 days. If necessary, courses are repeated 4-6 times a year.
Pharmacodynamics
A non-essential amino acid, a central inhibitory neurotransmitter. Improves metabolic processes in brain tissue, has an antidepressant and sedative effect. It has glycine- and GABA-ergic, alpha1-adrenergic blocking, antioxidant and antitoxic effects; regulates the activity of glutamate (NMDA) receptors, thereby reducing psycho-emotional stress, aggressiveness and conflict; improves social adaptation and mood; makes it easier to fall asleep and normalizes sleep; increases mental performance; reduces the severity of vegetative-vascular disorders (including during menopause) and cerebral disorders in ischemic stroke and traumatic brain injury, the toxic effect of ethanol on the central nervous system.
Pharmacokinetics
Easily penetrates into most biological fluids and body tissues, including the brain, and does not accumulate. It is quickly destroyed in the liver by glycine oxidase to water and carbon dioxide.
Indications for use Glycine-bio pharmaplant 100 mg 50 pcs. sublingual tablets
Stressful conditions (including psycho-emotional stress), decreased mental performance, deviant forms of behavior in children and adolescents, various functional and organic diseases of the nervous system, accompanied by increased excitability, emotional instability, decreased mental performance and sleep disturbances: neuroses, neurosis-like conditions, consequences of neuroinfections and traumatic brain injury, perinatal and other forms of encephalopathies (including alcoholic origin).
Ischemic stroke.
In narcology - as medicines that increase mental performance and reduce psycho-emotional stress during the period of remission in cases of encephalopathy, organic lesions of the central and peripheral nervous system.
Contraindications
Hypersensitivity.
With caution: arterial hypotension.
Application of Glycine-bio pharmaplant 100 mg 50 pcs. sublingual tablets during pregnancy and breastfeeding
There are no contraindications.
special instructions
In patients with a tendency to arterial hypotension, the prescription is made in smaller doses and with blood pressure under control; when it decreases below the usual level, the intake is stopped.
Side effects Glycine-bio pharmaplant 100 mg 50 pcs. sublingual tablets
Allergic reactions.
Drug interactions
Reduces the severity of side effects of antipsychotic drugs (neuroleptics), anxiolytics, antidepressants, hypnotics and anticonvulsants.
Analogs
Level 4 ATX code matches:
Bravinton
Acefen
Carnicetine
Pyracesin
Nooclerin
Semax
Piracetam
Olatropil
Fezam
Vinpocetine
Cerebrocurin
Cavinton Forte
Calcium hopantenate
Glutamic acid
Cephabol
Olanzapine
Cerebrolysate
Pramistar
Sidnocarb
Vinpotropil
There are a number of analogues of this drug. These are the drugs Glycine Ozone , Glycised , Glycine Forte , Glycine Biotics and other drugs whose active ingredient is glycine. But only a doctor should choose the most suitable drug in each case.
Composition/description
Registration number: LSR-001431/07
Trade name: Glycine
International nonproprietary name:
glycine.
Dosage form:
sublingual tablets.
Composition per tablet:
microencapsulated glycine (in terms of the active ingredient glycine - 100 mg), excipients: methylcellulose - 1 mg, magnesium stearate - 1 mg.
Description:
round flat-cylindrical tablets of white or almost white color with marbling elements with a chamfer and a score.
